View all blogs:
Liposomal generics in Asia: Supporting scalable drug delivery through GMP lipid excellence
Pharma
Across Asia, healthcare systems are balancing rising disease burden, expanding access expectations, and increasing cost pressures, making generic medicines central to national healthcare strategies
A 3rd Consecutive Win: Croda Pharma Awarded Pharma Excipients Champion and Sustainability Influencer Award at CPHI China
Pharma
Croda Pharma Secures New Wins in Pharmaceutical Excipients and Sustainability
Croda nominated for Low Carbon Industrial Project of the Year award at the UK Green Business Awards 2026
Pharma
Each year, the UK Green Business Awards offer a unique opportunity to highlight some of the most exciting, inspiring, and innovative companies, projects, and campaigns operating in the UK today, while...
Consumer trends: how consumer expectations are reshaping topical pharmaceuticals
Pharma
The topical pharmaceutical game is changing. Success is no longer shaped by efficacy alone, with consumer’s expectations increasingly redefining the industry.
Croda’s Avanti Research™ expands advanced lipid technologies through collaboration with NovoArc
Pharma
Avanti Polar Lipids, LLC, a wholly owned subsidiary of Croda International Plc, and NovoArc GmbH (NovoArc) are pleased to announce a strategic collaboration to expand global access to advanced lipid...
Partnership to protect biodiversity
Pharma
Discover how Sustainably Sourced Squalene relates to the advice from the IPBES, the Intergovernmental Science-Policy Platform on Biodiversity and Ecosystem Services (IPBES).
Replacing Triton™ X‑100 Without Compromise: Meet Virodex™
Pharma
If you were at BioProcess International Europe this year, you may have caught a glimpse of us talking about detergent alternatives for viral inactivation. If you weren’t, or if you’ve since heard the...
Bioprocessing spotlight: Meet the Croda Pharma experts heading to BioProcess International Europe
Pharma
As BioProcess International Europe in Vienna approaches this Spring, we’re excited to take part in the conversations around technologies, trends and meet the people translating science into progress.
BioXPro™ high purity amino acids now available
Pharma
Croda successfully launches new Amino Acid range BioXPro™: Croda International Plc (“Croda”) today confirms the successful introduction of its latest portfolio of high purity amino acids, developed to...
Spotlight on Amino Acids with Christian Wells
Pharma
This week we sat down with Christian Wells to discuss all things amino acids
Meeting the demand for sulphate-free oral care
Pharma
Formulators are seeking gentle yet effective surfactants that meet regulatory and consumer expectations. That’s where Adinol™ CT95 comes in...
Spotlight on R&D - Tina Baharlou, Industrial Placement Student
Pharma
This week we caught up with Tina Baharlou, a current Industrial placement student based at our Head Office labs in the UK. Tina has spent the past year immersed in advanced formulation work focused on...
An FAQ session with our lanolin manufacturing experts
Pharma
We sat down with our manufacturing experts to discuss lanolin
The Nitrosamine challenge in pharmaceuticals
Pharma
Since 2018 the risk of nitrosamine impurities in medicinal products has become a critical concern for pharmaceutical manufacturers and regulators alike
Gain insights from our experts...
Pharma
Explore our poster: Optimising lipid nanoparticles (LNPs) processing for siRNA delivery by microfluidics system. The success of mRNA vaccines during the COVID-19 pandemic has accelerated the...
Croda celebrates opening of expanded UK facility, bolstering global Super Refined™ capabilities
Pharma
Croda International Plc (“Croda”), the company that uses smart science to create high-performance ingredients and pharmaceutical excipients that improve lives, celebrated the opening of its newly...
Spotlight on R&D: Geoff Platt
Pharma
This week we spoke to Geoff Platt, Technology Specialist based at our Head Office labs in the UK. Keep reading to learn more about Geoff's background, Protein Delivery challenges, innovations and the...
Croda welcomes Thomas Riermeier as new President of Life Sciences
Pharma
Croda International Plc, the company that uses smart science to create ingredients and technologies that improve lives, today announces that Dr. Thomas Riermeier has been appointed as the new...
From Lab to Patient: Optimising Oncology Formulations with Purified Excipients
Pharma
In 2024, we hosted a live webinar exploring the impact of our Super RefinedTM excipients on various chemotherapeutic formulations. This blog will explore some of the key learnings from the webinar.
Croda’s Avanti Research expands ionizable lipid offering for LNP drug development through Certest collaboration
Pharma
Avanti Polar Lipids, LLC, a wholly owned subsidiary of Croda International Plc, and Certest Biotec S.L. (Certest) are pleased to announce a strategic collaboration to expand the market’s access to...
Lets connect...
Register to the mailing list to unlock:
- First access to new products, new data and exclusive literature
- Whitepapers and thought provoking content
- Special offers on conference and exhibition passes when available
- Invitations to invite only Croda Pharma events.